COMP <GO>
IPAR vs SCL // EV/EBITDA & P/E VALUATION
Interparfums Inc. (NASDAQ) VS. Stepan Company (NYSE) • 15-METRIC TALLY: IPAR 9
— SCL 2
▲ EV/EBITDA & P/E VALUATION LEADER: SCL
LAST: $115.50 (+1.10%) • MKT CAP: $3.70B
valuation
13.1x
LAST: $69.99 (+2.31%) • MKT CAP: $1.59B
valuation
9.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IPAR VS. SCL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IPAR | SCL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 63.60% | 11.60% | +52.00 | IPAR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.30% | 4.30% | +17.00 | IPAR | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.1x | 9.8x | +3.30 | SCL | /valuation <GO> |
| Free Cash Flow Yield | 5.15% | 1.59% | +3.56 | IPAR | /fcf-yield <GO> |
| Operating Margin | 18.20% | 3.40% | +14.80 | IPAR | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 2.00% | +12.00 | IPAR | /net-margins <GO> |
| Revenue Growth (YoY) | — | 7.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.78% | 2.20% | +0.58 | IPAR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.36 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | IPAR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.4 | 76.2 | -20.86 | SCL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.6x | 31.5x | -14.90 | IPAR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.70B | $1.59B | $2.11B | IPAR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IPAR REV | SCL REV | IPAR GROSS % | SCL GROSS % | IPAR FCF | SCL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $2.33B | 63.6% | 11.6% | $190.5M | $25.4M |
| FY 2024 | $1.45B | $2.18B | 63.9% | 12.5% | $182.9M | $39.3M |
| FY 2023 | $1.32B | $2.33B | — | — | $105.8M | $174.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IPAR // BETA —
SCL // BETA —